-
A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysi
Author: Sawa, Masashi; Miyamoto, Toshihiro; Kim, Hee-Je; Hiramatsu, Yasushi; Cheong, June-Won; Ikezoe, Takayuki; Naoe, Tomoki; Akashi, Koichi; Morita, Satoshi; Kosako, Masanori; Shimura, Masaki; Terada, Wataru; Kadokura, Takeshi; Hill, Jason; Miyawaki, Shuichi; Gill, Stanley C.; Heinloth, Alexandra; Hasabou, Nahla
Journal: THERAPEUTIC ADVANCES IN HEMATOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20406207261419953
-
Assessment of flonoltinib maleate versus ruxolitinib phosphate in intermediate- to high-risk myelofibrosis (FMF-02): study protocol for a multicenter, randomized, open-label phase IIB tria
Author: Yang, Linyu; Tan, Ke; Liang, Rui; Zhang, Wei; Wang, Yiqun; Chen, Lijuan
Journal: THERAPEUTIC ADVANCES IN HEMATOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20406207261424845
-
The impact of clinical manifestations on the prognosis of diffuse large B-cell lymphom
Author: Wang, Siqian; Xu, Xi; Ma, Yongyong; Qian, Shanhu; Tang, Liyuan; Sun, Lan; Shen, Zhijian; Ye, Haige; Qian, Honglan; Jiang, Songfu; Zhou, Shujuan
Journal: THERAPEUTIC ADVANCES IN HEMATOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20406207251410405
-
Early-onset de novo donor-specific anti-HLA antibodies may contribute to poor graft function following haploidentical transplantation for myelodysplastic syndrome: a rare case presentatio
Author: Huang, Xianbo; Wu, Xianhui; Wang, Shasha; Xu, Yu; Mei, Chen; Du, Fengwei; Ren, Yanling; Jin, Jie; Tong, Hongyan; Qian, Jiejing
Journal: THERAPEUTIC ADVANCES IN HEMATOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20406207261417496
-
Real-world clinical outcomes of autologous stem cell transplantation in Chinese patients with newly diagnosed multiple myeloma: a systematic literature revie
Author: You, Jiawen; Zhang, Yuanyuan; Meng, Yuan; Zhao, Yiming; Huang, Huiqing; Chen, Wendong; Meng, Jianbo
Journal: THERAPEUTIC ADVANCES IN HEMATOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20406207261417132
-
Endothelial dysfunction and cardiac damage indicators in patients with β-thalassemia major under iron-chelation therap
Author: Al-Sanabra, Ola M.; Abbas, Manal A.; Haza, Wafa J.; Hazaa, Abeer A
Journal: THERAPEUTIC ADVANCES IN HEMATOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20406207261417140
-
Comparing two different doses of anti-thymocyte globulin in allogeneic hematopoietic stem cell transplantation for transfusion-dependent thalassemia: an open-label, randomized clinical tria
Author: Huang, Qiulin; Liu, Rongrong; Zheng, Baoshi; Liu, Lianjin; Xiao, Hongwen; Wu, Meiqing; Shi, Lingling; Yang, Gaohui; Wei, Zhenbin; Zhou, Qi; Chen, Yinghua; Liu, Yanye; Fan, Jing; Zhou, Xuemei; Li, Ruolin; Zeng, Zhiyu; Zhang, Zhongming; Lai, Yongrong
Journal: THERAPEUTIC ADVANCES IN HEMATOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20406207261416816
-
Recombinant von Willebrand factor for von Willebrand disease: mechanism of action and clinical applicatio
Author: Hua, Zhengjie; Miao, Wenjuan; Zhang, Ping; Yang, Renchi
Journal: THERAPEUTIC ADVANCES IN HEMATOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20406207261419941
